Afficher la notice abrégée

dc.contributor.authorCallejas Rubio, José Luis 
dc.contributor.authorAomar Millán, I.
dc.contributor.authorMoreno Higueras, M.
dc.contributor.authorMartín Ripoll, L.
dc.contributor.authorYuste Osorio, E.
dc.contributor.authorRios Fernández, Raquel
dc.date.accessioned2025-01-28T11:21:59Z
dc.date.available2025-01-28T11:21:59Z
dc.date.issued2021-12
dc.identifier.citationCallejas Rubio JL, Aomar Millan I, Moreno-Higueras M, Martín Ripoll L, Yuste Osorio E, Ríos-Fernández R. Caution with the use of dexamethasone in patients with COVID-19 in its initial phases. Rev Clin Esp (Barc). 2021 Dec;221(10):592-595. doi: 10.1016/j.rceng.2021.02.005. Epub 2021 Sep 17. (IF: 1.3; Q3)es_ES
dc.identifier.urihttps://hdl.handle.net/10481/100736
dc.languageeng
dc.publisherRev Clin Espes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleCaution with the use of dexamethasone in patients with COVID-19 in its initial phaseses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/j.rceng.2021.02.005


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional